메뉴 건너뛰기
Fudan University Journal of Medical Sciences
Volumn 30, Issue 2, 2003, Pages
Preparation of anti-HER2/neu monoclonal antibody and its inhibiting ability on the growth of breast carcinoma cells
Author keywords

Breast carcinoma; HER2 neu2 oncogene; Monoclonal antibody
Indexed keywords

CARCINOGENS; CLONING; DRUG THERAPY; IMMUNIZATION; PROTEINS; TUMORS;
EID: 0037997110     PISSN: 16728467     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)
References (8)
  • 1
    • 0028176477 scopus 로고
    • A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling
    • Caraway KL, Cantley LC. A neu acquaintance for ErbB3 and ErbB4: a role for receptor heterodimerization in growth signaling. Cell, 1994, 78:5
    • (1994) Cell , vol.78 , pp. 5
    • Caraway, K.L.1    Cantley, L.C.2
  • 2
    • 0030944455 scopus 로고    scopus 로고
    • Erb-B-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
    • Graus-Porta D, Beerli RR, Daly JM, et al. Erb-B-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBCO J, 1997, 16:1647
    • (1997) EMBCO J , vol.16 , pp. 1647
    • Graus-Porta, D.1    Beerli, R.R.2    Daly, J.M.3
  • 3
    • 0028670125 scopus 로고
    • The biology of erbB-2/neu/HER2 and its role in cancer
    • Hynes, NE, Stern DF. The biology of erbB-2/neu/HER2 and its role in cancer. Biochem Biophys Acta, 1994, 1198:165
    • (1994) Biochem Biophys Acta , vol.1198 , pp. 165
    • Hynes, N.E.1    Stern, D.F.2
  • 4
    • 0032078876 scopus 로고    scopus 로고
    • ERBB2 oncogenes in human breast cancer and its clinical significance
    • Revillion F, Bonneterre J, Peyrat JP. ERBB2 oncogenes in human breast cancer and its clinical significance. Eur J Cancer, 1998, 34: 791
    • (1998) Eur J Cancer , vol.34 , pp. 791
    • Revillion, F.1    Bonneterre, J.2    Peyrat, J.P.3
  • 5
    • 0027375130 scopus 로고
    • Diffential responses of human cancer cell lines to anti-p185HER2 monoclonal antibodies
    • Lewis GD, Figari I, Fendly B, et al. Diffential responses of human cancer cell lines to anti-p185HER2 monoclonal antibodies. Cancer Immunol Immunotherapy, 1993, 37:255
    • (1993) Cancer Immunol Immunotherapy , vol.37 , pp. 255
    • Lewis, G.D.1    Figari, I.2    Fendly, B.3
  • 6
    • 0030586928 scopus 로고    scopus 로고
    • Recovery of biologically active proteins detected with imidazole-sodium Dodecyl sulfate-zine (reverse stain) on sodium Dodecyl sulfate gel
    • Hardy E, Santana H, Sosa A, et al. Recovery of biologically active proteins detected with imidazole-sodium Dodecyl sulfate-zine (reverse stain) on sodium Dodecyl sulfate gel. Anal Biochem, 1996, 240:150
    • (1996) Anal Biochem , vol.240 , pp. 150
    • Hardy, E.1    Santana, H.2    Sosa, A.3
  • 7
    • 0033009904 scopus 로고    scopus 로고
    • C-erb-B2 (HER - 2/ neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy
    • Vargas-Roig LM, Gago FE, Tello O, et al. C-erb-B2 (HER - 2/ neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer, 1999, 84 (2):129
    • (1999) Int J Cancer , vol.84 , Issue.2 , pp. 129
    • Vargas-Roig, L.M.1    Gago, F.E.2    Tello, O.3
  • 8
    • 0032445260 scopus 로고    scopus 로고
    • HER - 2/neu as a predictive marker of responses to breast cancer research
    • Pegram MD, Pauletti G, Slamon DJ. HER - 2/neu as a predictive marker of responses to breast cancer research. Breast Cancer Res Treat, 1998, 52(1):65
    • (1998) Breast Cancer Res Treat , vol.52 , Issue.1 , pp. 65
    • Pegram, M.D.1    Pauletti, G.2    Slamon, D.J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.